Target intelligence / Profile preview

Glucoregulatory metabolic pathways

Molecular classification
Other
01

Overview

Glucoregulatory metabolic pathways are a set of interconnected biochemical routes responsible for maintaining glucose levels within organisms. Major pathways include glycolysis, gluconeogenesis, and glycogen metabolism, each regulated by specific enzymes, transporters, and hormonal signals. These pathways dictate cellular energy production, storage, and utilization, while feedback and gene expression systems enable adaptation to physiological demands. They are disrupted in various metabolic diseases and are exploited as therapeutic targets, particularly in diabetes, obesity, and cancer[1][3][4]. In summary, "Glucoregulatory metabolic pathways" is not a canonical molecule or receptor, but an umbrella term for a group of pathways; thus, it is not a drug target in singular form[1][3]. For molecular drugs or targets, individual enzymes, transporters, or receptors within these pathways (e.g., GLUTs, hexokinase, glucokinase, insulin receptor) should be specified.

Other names
glucose metabolismcarbohydrate metabolismenergy-yielding pathways for glucose
02

Mechanism of action

Enzyme inhibition (e.g., hexokinase, phosphofructokinase, pyruvate kinase); Modulation of glucose transport; Alteration of hormonal signaling (insulin, glucagon, etc.); Feedback inhibition in metabolic steps

03

Biological functions

Energy productionRegulation of blood glucose levelsBiosynthesis of macromoleculesMaintenance of cellular homeostasisResponse to hormonal signals (e.g., insulin, glucagon)
04

Disease associations

Cancer (metabolic reprogramming)Diabetes mellitusObesityNeurodegenerative diseasesCardiovascular diseaseOther metabolic disorders
05

Safety considerations

HypoglycemiaLactic acidosisOff-target toxicity affecting normal cell metabolism (especially relevant in cancer therapy)Loss of metabolic regulation with systemic effects
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

Blood glucoseHemoglobin A1cInsulin levelsKey pathway enzymes (e.g., hexokinase, glucokinase, phosphofructokinase)

Beyond the preview

Go deeper on Glucoregulatory metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucoregulatory metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call